A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Diabetes insípida nefrogénica; Diabetes insípida nefrógena adquirida; Diabetes insípida congénita
No se conoce prevención alguna para la diabetes insípida nefrógena de tipo congénito.
El tratamiento de los trastornos que pueden llevar a la forma adquirida de la enfermedad puede impedir su desarrollo en algunos casos. Los medicamentos sólo deben ser utilizados bajo la supervisión de un médico.
Verbalis JG. Posterior pituitary. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 243.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885